98%
921
2 minutes
20
This article reports on the clinical and genetic characteristics of monozygotic twins with Marshall-Smith syndrome (MRSHSS) due to a mutation in the gene, along with a review of related literature. Both patients presented with global developmental delays, a prominent forehead, shallow eye sockets, and pectus excavatum. Genetic testing revealed a heterozygous splicing site mutation c.697+1G>A in both children, with parents showing wild-type at this locus. According to the guidelines of the American College of Medical Genetics and Genomics, this mutation is considered likely pathogenic and has not been previously reported in the literature. A review of the literature identified 32 MRSHSS patients with splicing/frameshift mutations. Accelerated bone maturation and moderate to severe global developmental delay/intellectual disability are the primary clinical manifestations of patients with MRSHSS. Genetic testing results are crucial for the diagnosis of this condition.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562048 | PMC |
http://dx.doi.org/10.7499/j.issn.1008-8830.2401047 | DOI Listing |
Ophthalmic Genet
August 2025
Division of Neuro-Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Background: Malan syndrome, an overgrowth disorder caused by pathogenic gene variants, is characterized by macrocephaly, distinct facial features, and intellectual disability. This case highlights the associated ophthalmologic features of this rare condition.
Materials And Methods: We describe a young Spanish white man with progressive vision loss in the setting of a prior clinical diagnosis of Sotos syndrome, accompanied by developmental delay and epilepsy.
J Bone Miner Res
September 2024
Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Zhongguo Dang Dai Er Ke Za Zhi
July 2024
Department of Pediatrics, Xiangya Hospital, Central South University, Changsha 410008, China.
This article reports on the clinical and genetic characteristics of monozygotic twins with Marshall-Smith syndrome (MRSHSS) due to a mutation in the gene, along with a review of related literature. Both patients presented with global developmental delays, a prominent forehead, shallow eye sockets, and pectus excavatum. Genetic testing revealed a heterozygous splicing site mutation c.
View Article and Find Full Text PDFChilds Nerv Syst
August 2024
Department of Neurosurgery, New Jersey Pediatric Neuroscience Institute, Morristown, NJ, USA.
Marshall-Smith Syndrome (MSS) is a rare progressive developmental disorder that severely impairs a patient's intellectual development and physical health. The only known cause for MSS is a mutation in the nuclear factor 1 X (NFIX) gene. This mutation affects neuronal development and protein transcription.
View Article and Find Full Text PDFAm J Med Genet A
May 2024
Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
The NFIX gene encodes a DNA-binding protein belonging to the nuclear factor one (NFI) family of transcription factors. Pathogenic variants of NFIX are associated with two autosomal dominant Mendelian disorders, Malan syndrome (MIM 614753) and Marshall-Smith syndrome (MIM 602535), which are clinically distinct due to different disease-causing mechanisms. NFIX variants associated with Malan syndrome are missense variants mostly located in exon 2 encoding the N-terminal DNA binding and dimerization domain or are protein-truncating variants that trigger nonsense-mediated mRNA decay (NMD) resulting in NFIX haploinsufficiency.
View Article and Find Full Text PDF